KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

Lion Point Capital, LP's Holding History (CIK: 0001643354)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 130,691 Value ($000) $2,579 Avg Close — Range —
Q4 2023
Shares 130,691 Value ($000) $2,292 Avg Close — Range —
Q3 2023
Shares 130,691 Value ($000) $2,270 Avg Close — Range —
Q2 2023
Shares 130,691 Value ($000) $1,840 Avg Close — Range —
Q1 2023
Shares 113,540 Value ($000) $1,222 Avg Close — Range —
Q4 2022
Shares 346,500 Value ($000) $3,689 Avg Close — Range —
Q3 2022
Shares 480,000 Value ($000) $5,140 Avg Close — Range —
Q2 2022
Shares 480,000 Value ($000) $5,140 Avg Close — Range —
Q1 2022
Shares 480,000 Value ($000) $4,771 Avg Close — Range —
Q4 2021
Shares 55,000 Value ($000) $647 Avg Close — Range —
Q3 2021
Shares 495,748 Value ($000) $5,646 Avg Close — Range —
Q2 2021
Shares 495,748 Value ($000) $6,905 Avg Close — Range —
Q1 2021
Shares 495,748 Value ($000) $9,176 Avg Close — Range —
Q4 2020
Shares 495,748 Value ($000) $8,759 Avg Close — Range —
Q3 2020
Shares 495,748 Value ($000) $7,594 Avg Close — Range —
Q2 2020
Shares 495,748 Value ($000) $12,631 Avg Close — Range —
Q1 2020
Shares 495,748 Value ($000) $7,674 Avg Close — Range —